Moneycontrol PRO
Loans
Loans
HomeNewsGepowerindia

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Mahindra Ugine, IVRCL, Alembic Pharma: Rajesh Agarwal

    Buy Mahindra Ugine, IVRCL, Alembic Pharma: Rajesh Agarwal

    Rajesh Agarwal of Eastern Financiers suggests buying Mahindra Ugine Steel Company, IVRCL, Lakshmi Vilas Bank and Alembic Pharmaceuticals.

  • Bull's Eye: Buy IVRCL, GSFC, Tech Mahindra; short Petronet

    Bull's Eye: Buy IVRCL, GSFC, Tech Mahindra; short Petronet

    Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.

  • Avoid Alembic Pharma, says SP Tulsian

    Avoid Alembic Pharma, says SP Tulsian

    SP Tulsian, sptulsian.com advises traders to avoid Alembic Pharma at current levels.

  • Buy Alembic Pharmaceutical, Dishman Pharma, NHPC: Agarwal

    Buy Alembic Pharmaceutical, Dishman Pharma, NHPC: Agarwal

    In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.

  • Alembic Pharma likely to touch Rs 82-84, says Tulsian

    Alembic Pharma likely to touch Rs 82-84, says Tulsian

    SP Tulsian of sptulsian.com advised buying Alembic Pharma at around Rs 82-84. He expects the stock to hit these levels in a week.

  • Bull's eye: Buy IndusInd Bank, NHPC, SKS Micro, PFC

    Bull's eye: Buy IndusInd Bank, NHPC, SKS Micro, PFC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Alembic Pharma has target of Rs 100: SP Tulsian

    Alembic Pharma has target of Rs 100: SP Tulsian

    Alembic Pharma has target of Rs 100, says SP Tulsian, sptulsian.com

  • KYI: How you should trade stocks next week

    KYI: How you should trade stocks next week

    It was a volatile day on the Dalal Street as the markets turned around in late trade. Indices closed flat after a weak start. The Nifty closed just shy of 5,900 and the Sensex ended at 19,468.

  • Tata Motors, M&M top picks in auto space: Raheja

    Tata Motors, M&M top picks in auto space: Raheja

    Tata Motors and M&M are top picks in auto space, says Nitin Raheja, CIO, AQF Advisors.

  • Buy Alembic Pharma, Tata Global, RCF: Sharmila Joshi

    Buy Alembic Pharma, Tata Global, RCF: Sharmila Joshi

    In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi, Fairwealth Securities shares trading strategy of the day.

  • Bull's eye: Buy IVRCL, NCC; short MTNL, Maruti

    Bull's eye: Buy IVRCL, NCC; short MTNL, Maruti

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy Chambal Fert, RCF, Axis Bank, MTNL

    Bull's eye: Buy Chambal Fert, RCF, Axis Bank, MTNL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Tulsian's multibaggers: Alembic, Techno Electric

    Tulsian's multibaggers: Alembic, Techno Electric

    Market expert SP Tulsian, sptulsian.com picked pharma company Alembic and EPC player Techno Electric as his multibagger stocks. He expects these stocks to fetch better returns ahead.

  • Alembic Pharma can touch Rs 75: SP Tulsian

    Alembic Pharma can touch Rs 75: SP Tulsian

    Alembic Pharmaceuticals can touch Rs 75 in next six months, says SP Tulsian, sptulsian.com. I am quite bullish on FY14 going forward because by then they should be able to take their topline close to about Rs 2,000 crore with EPS of close to about Rs 10.

  • Buy Alembic Pharma, Peninsula Land: SP Tulsian

    Buy Alembic Pharma, Peninsula Land: SP Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Bull's Eye: Short HUL, Sesa Goa, Idea; buy Cairn

    Bull's Eye: Short HUL, Sesa Goa, Idea; buy Cairn

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's Eye: Buy Dishman Pharma, HOEC,, McLeod Russel

    Bull's Eye: Buy Dishman Pharma, HOEC,, McLeod Russel

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's Eye: Buy Suzlon, ITC, BPCL, Tata Motors

    Bull's Eye: Buy Suzlon, ITC, BPCL, Tata Motors

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Alembic Pharma has target of Rs 80: PN Vijay

    Alembic Pharma has target of Rs 80: PN Vijay

    Alembic Pharmaceuticals has target of Rs 80, says PN Vijay, Portfolio Manager.

  • Bull's Eye: Buy Manappuram Fin, VIP Ind, Tata Coffee

    Bull's Eye: Buy Manappuram Fin, VIP Ind, Tata Coffee

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347